GlassScriptPhysician profile
Judson Brandeis
NPI 1831197920
$1,594.52
in general payments reported to CMS, 2019-2025
9 companies · $237 in 2025
The $237 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $870 · 2020: $16.36 · 2021: $135 · 2022: $274 · 2024: $61.37 · 2025: $237.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $298.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coloplast Corp | $711.86 | 2019 | |
| Endo Pharmaceuticals INC. | $365.80 | 2019-2022 | |
| Tolmar, INC. | $186.50 | 2025 | Jatenzo |
| Endo USA, INC. | $112.02 | 2024-2025 | Xiaflex |
| Antares Pharma, INC. | $100.02 | 2019-2022 | |
| Janssen Biotech, INC. | $56.51 | 2019 | |
| Acerus Pharmaceuticals Corporation | $24.11 | 2022 | |
| Procept Biorobotics Corporation | $20.51 | 2019 | |
| Metuchen Pharmaceuticals | $17.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Judson Brandeis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.